Format

Send to

Choose Destination
Biomed Res Int. 2017;2017:4126740. doi: 10.1155/2017/4126740. Epub 2017 Dec 20.

Clinicopathological Characteristics, Treatment, and Prognosis of Rarely Primary Epididymal Adenocarcinoma: A Review and Update.

Author information

1
Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
2
Department of Urology, Sichuan Cancer Hospital & Institute, Chengdu, Sichuan 610041, China.
3
Department of Urology, Fujian Provincial Hospital, Fuzhou, Fujian 350001, China.

Abstract

Primary epididymal adenocarcinoma (PEA) is exceedingly rare. Only 22 cases had been published worldwide by 2008; nearly 80% of these cases were reported before 2007. In order to investigate the current clinical status of PEA, we search for relevant literatures with "epididymis and adenocarcinoma" and "epididymal and adenocarcinoma" as keywords published between January 1997 and November 2017 in PubMed. As a result, 17 cases are identified. We review these cases and summarize new and important perspectives about the clinicopathological characteristics, diagnosis, treatment, and prognosis of PEA in the present review.

PMID:
29423406
PMCID:
PMC5750466
DOI:
10.1155/2017/4126740
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center